Emmanuel Gyan

10.8k total citations
164 papers, 2.7k citations indexed

About

Emmanuel Gyan is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Emmanuel Gyan has authored 164 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pathology and Forensic Medicine, 61 papers in Genetics and 50 papers in Oncology. Recurrent topics in Emmanuel Gyan's work include Lymphoma Diagnosis and Treatment (65 papers), Acute Myeloid Leukemia Research (38 papers) and Chronic Lymphocytic Leukemia Research (31 papers). Emmanuel Gyan is often cited by papers focused on Lymphoma Diagnosis and Treatment (65 papers), Acute Myeloid Leukemia Research (38 papers) and Chronic Lymphocytic Leukemia Research (31 papers). Emmanuel Gyan collaborates with scholars based in France, United States and Belgium. Emmanuel Gyan's co-authors include Gilles Salles, Guillaume Cartron, Olivier Hérault, Michaëla Fontenay, Rémy Gressin, Steven Le Gouill, Éric Solary, Catherine Thiéblemont, Franck Morschhauser and Séverine Cathelin and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Emmanuel Gyan

158 papers receiving 2.7k citations

Peers

Countries citing papers authored by Emmanuel Gyan

Since Specialization

Citations

This map shows the geographic impact of Emmanuel Gyan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emmanuel Gyan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emmanuel Gyan more than expected).

Fields of papers citing papers by Emmanuel Gyan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emmanuel Gyan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emmanuel Gyan. The network helps show where Emmanuel Gyan may publish in the future.

Co-authorship network of co-authors of Emmanuel Gyan

This figure shows the co-authorship network connecting the top 25 collaborators of Emmanuel Gyan. A scholar is included among the top collaborators of Emmanuel Gyan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emmanuel Gyan. Emmanuel Gyan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Maintenance therapy with the FMS‐like tyrosine kinase 3 inhibitor gilteritinib in patients with FMS‐like tyrosine kinase 3–internal tandem duplication acute myeloid leukemia: A phase 2 study 2025 ·Cancer ·Emmanuel Gyan, (unknown), (unknown), Alessandro Rambaldi, Gunnar Juliusson, Martin Jädersten, Richard Kelly, (unknown), Wensheng He, Stanley C. Gill, Jason E. Hill, (unknown), David Delgado‐Gómez, Nahla Hasabou	2
2	Combining ESA and Luspatercept in Non-RS MDS Patients Having Failed ESA - Results of the Phase 1-2 Part a of the GFM Combola Study 2024 ·Blood ·Lionel Adès, Thomas Cluzeau, Thibault Comont, (unknown), Aspasia Stamatoullas, (unknown), Emmanuel Gyan, Alice Garnier, Maud D’Aveni, Sylvain Thépot, Marie Sébert, (unknown), Anouk Walter‐Petrich, (unknown), Fatiha Chermat, Michaëla Fontenay, Sylvie Chevret, (unknown)	3
3	Modulation of bone marrow and peripheral blood cytokine levels by age and clonal hematopoiesis in healthy individuals 2023 ·Clinical Immunology ·(unknown), Hélène Guermouche, Pierre Hirsch, Frédéric Picou, (unknown), Nathalie Gallay, (unknown), (unknown), Ludovic Suner, Caroline Deswarte, Sébastien Lachot, (unknown), Laëtitia Largeaud, Valérie Gissot, Marie C. Béné, Emmanuel Gyan, François Delhommeau, Olivier Hérault	11
4	Facteurs pronostiques des syndromes myélodysplasiques 2023 ·Bulletin du Cancer ·Emmanuel Gyan, Sylvain Thépot	0
5	Cerebral localization of chronic myelomonocytic leukemia and improvement with high‐dose cytarabine: A case report 2023 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Laurianne Drieu La Rochelle, Nicolas Vallet, Julien Lejeune, (unknown), Jean‐Philippe Cottier, Olivier Hérault, Emmanuel Gyan	1
6	Specific Changes of Erythroid Regulators and Hepcidin in Patients Infected by SARS-COV-2 2022 ·Journal of Investigative Medicine ·(unknown), (unknown), Nicolas Vallet, Charlotte Veyrat‐Durebex, Louis Bernard, Olivier Hérault, Martine Ropert, Julien Marlet, Emmanuel Gyan, Christian Andrés, Hélène Blasco, Éric Piver	7
7	Low-Dose Pesticides Alter Primary Human Bone Marrow Mesenchymal Stem/Stromal Cells through ALDH2 Inhibition 2021 ·Cancers ·(unknown), (unknown), (unknown), Frédéric Picou, Nathalie Gallay, (unknown), Jérôme Bourgeais, (unknown), Jorge Domenech, Pascal Loyer, Nicolas Vallet, Julien Lejeune, Emmanuel Gyan, Marie C. Béné, François M. Vallette, (unknown), Olivier Hérault	10
8	Automated Early Detection of Myelodysplastic Syndrome within the General Population Using the Research Parameters of Beckman–Coulter DxH 800 Hematology Analyzer 2021 ·Cancers ·(unknown), (unknown), Frédéric Picou, (unknown), (unknown), Julien Lejeune, Nicolas Vallet, Sébastien Lachot, (unknown), Emmanuel Gyan, Marie C. Béné, Olivier Hérault	14
9	Antibody Responses after a Third Dose of COVID-19 Vaccine in Kidney Transplant Recipients and Patients Treated for Chronic Lymphocytic Leukemia 2021 ·Vaccines ·Julien Marlet, Philippe Gatault, (unknown), Hélène Longuet, Karl Stéfic, Lynda Handala, Sébastien Eymieux, Emmanuel Gyan, Caroline Dartigeas, Catherine Gaudy‐Graffin	29
10	Optimal exposure factors for lumbar spine AP in computed radiography examinations 2021 ·Iranian Journal of radiation research ·Emmanuel Gyan, (unknown), (unknown)	0
11	Horizontal meta-analysis identifies common deregulated genes across AML subgroups providing a robust prognostic signature 2020 ·Blood Advances ·Ali Nehme, (unknown), Frédéric Picou, Meyling Cheok, Claude Preudhomme, Hervé Dombret, Juliette Lambert, Emmanuel Gyan, (unknown), Christian Récher, (unknown), Fabrice Gouilleux, Kazem Zibara, Olivier Hérault, Frédéric Mazurier	10
12	High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers 2020 ·Blood Advances ·Hélène Guermouche, (unknown), Nathalie Gallay, Caroline Deswarte, (unknown), (unknown), (unknown), (unknown), Sébastien Lachot, (unknown), Valérie Gissot, Ludovic Suner, Emmanuel Gyan, François Delhommeau, Olivier Hérault, Pierre Hirsch	33
13	Involvement of GPx-3 in the Reciprocal Control of Redox Metabolism in the Leukemic Niche 2020 ·International Journal of Molecular Sciences ·Christine Vignon, Christelle Debeissat, Jérôme Bourgeais, Nathalie Gallay, (unknown), Adrienne Anginot, Frédéric Picou, Philippe Guardiola, (unknown), (unknown), (unknown), Louis‐Romée Le Nail, Jorge Domenech, Marie C. Béné, Marie‐Caroline Le Bousse‐Kerdilès, Emmanuel Gyan, Olivier Hérault	7
14	Entrance skin dose assessment of selected computed radiography facilities in Ghana 2020 ·Iranian Journal of radiation research ·Emmanuel Gyan, (unknown), (unknown)	1
15	n-3 Polyunsaturated fatty acids induce acute myeloid leukemia cell death associated with mitochondrial glycolytic switch and Nrf2 pathway activation 2018 ·Pharmacological Research ·Frédéric Picou, Christelle Debeissat, Jérôme Bourgeais, Nathalie Gallay, (unknown), (unknown), (unknown), (unknown), Nicolas Vallet, (unknown), (unknown), Jorge Domenech, Olivier Hérault, Emmanuel Gyan	28
16	Glycemic dysregulation in a patient with type 2 diabetes treated with 5-azacitidine: a case report 2018 ·Journal of Medical Case Reports ·(unknown), Nicole Ferreira-Maldent, Marjan Ertault, Martine Delain, (unknown), Sandra Régina, A.‐P. Jonville‐Béra, Olivier Hérault, Philippe Colombat, Emmanuel Gyan	5
17	Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. 2015 ·Journal of Clinical Oncology ·Norbert Schmitz, Maike Nickelsen, Bettina Altmann, Marita Ziepert, Kamal Bouabdallah, Christian Gisselbrecht, (unknown), Guillaume Cartron, Emmanuel Gyan, Arnaud Jaccard, Laurence Sanhès, Philippe Gaulard, Andreas Rosenwald, Lorenz Truemper, Bertram Glaß, Peter Reimer, Wolfgang Herr, Martin Wilhelm, Olivier Tournilhac	18
18	A French National Survey on Clotting Disorders in Mastocytosis 2015 ·Medicine ·(unknown), Achille Aouba, Gandhi Damaj, Danielle Canioni, Chantal Brouzes, Emmanuel Gyan, S. Durupt, I. Durieu, P. Cathébras, N. Costedoat‐Chalumeau, David Launay, B. Pilmis, Stéphane Barète, Laurent Frenzel, Olivier Lortholary, Olivier Hermine, Cédric Hermans, Marie‐Olivia Chandesris	18
19	Long‐term follow‐up and second malignancies in 487 patients with hairy cell leukaemia 2014 ·British Journal of Haematology ·Édouard Cornet, Cécile Tomowiak, Aline Schmidt, Stéphane Leprêtre, Jehan Dupuis, Pierre Feugier, Alain Devidas, Clara Mariette, Véronique Leblond, Catherine Thiéblemont, (unknown), Laurent Sutton, Emmanuel Gyan, Jean‐Claude Eisenmann, Pascale Cony‐Makhoul, Loïc Ysebaert, Xavier Troussard, (unknown)	42
20	Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group 2010 ·Haematologica ·Rémy Gressin, Sylvie Caulet-Maugendre, Éric Deconinck, Olivier Tournilhac, Emmanuel Gyan, (unknown), (unknown), Jérôme Cornillon, Jean François Rossi, Steven Le Gouill, G. Lepeu, (unknown), (unknown), Hervé Maisonneuve, (unknown), Jean‐Pierre Vilque, Philippe Casassus, T. Lamy, (unknown), P Colombat, (unknown)	29

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact